BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan Y, Zhao S, Chen F. The potential value of dequalinium chloride in the treatment of cancer: Focus on malignant glioma. Clin Exp Pharmacol Physiol 2021;48:445-54. [PMID: 33496065 DOI: 10.1111/1440-1681.13466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang M, Lin K, Ramachandran M, Li L, Zou H, Zheng H, Ma Z, Li Y. A mitochondria-targeting lipid-small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.04.005] [Reference Citation Analysis]
2 Bailly C. Medicinal applications and molecular targets of dequalinium chloride. Biochem Pharmacol 2021;186:114467. [PMID: 33577890 DOI: 10.1016/j.bcp.2021.114467] [Reference Citation Analysis]
3 Belanger-Coast MG, Zhang M, Bugay V, Gutierrez RA, Gregory SR, Yu W, Brenner R. Dequalinium chloride is an antagonists of α7 nicotinic acetylcholine receptors. Eur J Pharmacol 2022;:175000. [PMID: 35525312 DOI: 10.1016/j.ejphar.2022.175000] [Reference Citation Analysis]
4 Charris KE, Rodrigues JR, Ramírez H, Fernandez-Moreira E, Ángel JE, Charris JE. Synthesis of 5H-indeno[1,2-b]pyridine derivatives: Antiproliferative and antimetastatic activities against two human prostate cancer cell lines. Arch Pharm (Weinheim) 2021;354:e2100092. [PMID: 33928662 DOI: 10.1002/ardp.202100092] [Reference Citation Analysis]